Tristel Plc -5.8% potential downside indicated by Numis

Tristel Plc with ticker (LON:TSTL) now has a potential downside of -5.8% according to Numis.



Numis set a target price of 390 GBX for the company, which when compared to the Tristel Plc share price of 414 GBX at opening today (07/06/2023) indicates a potential downside of -5.8%. Trading has ranged between 272 (52 week low) and 430 (52 week high) with an average of 51,483 shares exchanging hands daily. The market capitalisation at the time of writing is £192,337,943.

Tristel plc is a United Kingdom-based manufacturer of infection prevention products. The Company’s core business is the sale to hospitals of its chlorine dioxide chemistry used for the decontamination of medical devices under the Tristel brand, and for the sporicidal disinfection of environmental surfaces under the Cache brand. The Company’s segments include Hospital medical device decontamination, Hospital environmental surface disinfection and others. The Company manufactures and sells medical device decontamination products which are used primarily for infection control in hospitals. The Company also manufactures and sells hospital environmental surface disinfection products. The Company is also focused on pharmaceutical and personal care product manufacturing industries, veterinary and animal welfare sectors. The Tristel brand offers airway management, cardiology, ear, nose and throat, ophthalmology, endoscopy, surfaces, ultrasound, urology, hand hygiene and women’s health.